Register now and you will receive a link for the event.
April 20, 2021 from 1:30 pm - 2:30 pm EDT
Join our Industry Experts For Insights On The Evolution of Histopathology Within Regulatory Clinical Drug Trials.
Our expert panel will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including:
Followed by a panel discussion including questions from our viewers, led by Dr. Vipul Jairath, Chief Medical Officer, Alimentiv Inc.
Prior to Dr. Rubin’s current appointments, he served for 11 years as Director of Gastroenterology, Hepatology, and Nutrition… Read More
Dr. Pai has lectured nationally and internationally on many aspects of gastrointestinal and hepatic pathology and has directed multiple… Read More
Dr. Harrison is internationally known for studies in hepatitis C and non-alcoholic fatty liver disease with over 200 peer-reviewed… Read More